Medtronic's Diabetes Unit MiniMed Files For US IPO
Bearish
-50.0
Medtronic‘s (NYSE:MDT) diabetes unit, MiniMed Group, filed for a U.S. initial public offering (IPO) on Friday, as part of its separation from the medical devices maker.
The Northridge, California-based company reported a net loss of $21 million on net sales of $1.48 billion in the six months ended October 24, compared with a net loss of $23 million on net sales of $1.3 billion a year earlier, according to a regulatory filing with the U.S. Securities and Exchange Commission (SEC).
Medtronic To Retain Majority Voting Stock
MiniMed said that part of the proceeds from the IPO would be used to repay intercompany debt owed to Medtronic, with the remainder set aside for general corporate purposes.
The company, which makes insulin ...
The Northridge, California-based company reported a net loss of $21 million on net sales of $1.48 billion in the six months ended October 24, compared with a net loss of $23 million on net sales of $1.3 billion a year earlier, according to a regulatory filing with the U.S. Securities and Exchange Commission (SEC).
Medtronic To Retain Majority Voting Stock
MiniMed said that part of the proceeds from the IPO would be used to repay intercompany debt owed to Medtronic, with the remainder set aside for general corporate purposes.
The company, which makes insulin ...
Pulse AI Analysis
Pulse analysis not available yet. Click "Get Pulse" above.
This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.
